Diana Gallagher

Equibles does not estimate personal net worth.

Get an email with a short summary when Biogen Inc. publishes a filing, an earnings call transcript or a press release.

About Diana Gallagher

Diana Gallagher has spoken on 1 investor event across 1 company, most recently for Biogen Inc. on July 14, 2026. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Biogen Inc. includes Christopher A. Viehbacher (CEO and Board Member), Caroline D. Dorsa (Chairman), Michael R. McDonnell (CFO) and 7 others.

Diana Gallagher on recent calls

“Let's start with a reminder of the two targets most closely associated with Alzheimer's, amyloid and tau. While the current treatment landscape is focused on amyloid, research has also told us that tau, and more specifically, tau pathology spreading across the brain, is much more temporally linked to cognitive decline.”

Other, Biogen at the Alzheimer's Association International Conference (AAIC) 2026 · July 14, 2026